BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12857569)

  • 41. What role for mycophenolate mofetil in allogeneic hematopoietic cell transplantation?
    Storb R
    Transplantation; 2003 Aug; 76(4):747. PubMed ID: 12973126
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepatitis C and mycophenolate mofetil--a clarification.
    Fasola CG; Klintmalm GB
    Liver Transpl; 2002 Apr; 8(4):411-2; author reply 412-3. PubMed ID: 11965590
    [No Abstract]   [Full Text] [Related]  

  • 43. Graft-versus-host disease-like features in mycophenolate mofetil-related colitis.
    Papadimitriou JC; Drachenberg CB; Beskow CO; Cangro C; Wiland A; Klassen D; Weir M; Bartlett S
    Transplant Proc; 2001 May; 33(3):2237-8. PubMed ID: 11377513
    [No Abstract]   [Full Text] [Related]  

  • 44. Successful use of mycophenolate mofetil to treat severe chronic urticaria in a patient intolerant to ciclosporin.
    Raghavendran RR; Humphreys F; Kaur MR
    Clin Exp Dermatol; 2014 Jan; 39(1):68-9. PubMed ID: 23692555
    [No Abstract]   [Full Text] [Related]  

  • 45. Mycophenolate mofetil during pregnancy: some words of caution.
    Vento M; Perez Aytes A; Ledo A; Boso V; Carey JC
    Pediatrics; 2008 Jul; 122(1):184-5. PubMed ID: 18596003
    [No Abstract]   [Full Text] [Related]  

  • 46. Gastrointestinal pathological changes in stem cell transplant patients.
    Wong NA
    Curr Opin Support Palliat Care; 2014 Jun; 8(2):170-9. PubMed ID: 24717961
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rituximab in bronchiolitis obliterans after haematopoietic stem cell transplantation.
    Lorillon G; Robin M; Meignin V; Ribaud P; Lescoeur B; Gossot D; Socié G; Tazi A; Bergeron A
    Eur Respir J; 2011 Aug; 38(2):470-2. PubMed ID: 21804164
    [No Abstract]   [Full Text] [Related]  

  • 48. Mycophenolate mofetil therapy in a child with Churg-Strauss syndrome.
    Demircin G; Baysun S; Bülbül M; Erdoğan O; Oner A
    Pediatr Int; 2010 Jun; 52(3):e164-6. PubMed ID: 20723119
    [No Abstract]   [Full Text] [Related]  

  • 49. Mycophenolate mofetil for myasthenia gravis: an analysis of efficacy, safety, and tolerability.
    Meriggioli MN; Ciafaloni E; Al-Hayk KA; Rowin J; Tucker-Lipscomb B; Massey JM; Sanders DB
    Neurology; 2003 Nov; 61(10):1438-40. PubMed ID: 14638974
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Edema with hypoalbuminemia as a rare manifestation of chronic graft versus host disease after allogeneic hematopoietic cell transplant.
    Hogan JJ; Loren AW; Denker MG; Mangan JK
    Leuk Lymphoma; 2017 Aug; 58(8):2008-2010. PubMed ID: 27998198
    [No Abstract]   [Full Text] [Related]  

  • 51. How I treat refractory chronic graft-versus-host disease.
    Sarantopoulos S; Cardones AR; Sullivan KM
    Blood; 2019 Mar; 133(11):1191-1200. PubMed ID: 30674472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mycophenolate mofetil to the rescue in autoimmune hepatitis: a fresh sprout on the decision tree.
    Czaja AJ
    J Hepatol; 2009 Jul; 51(1):8-10. PubMed ID: 19446910
    [No Abstract]   [Full Text] [Related]  

  • 53. Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature.
    Caramaschi P; Volpe A; Carletto A; Bambara LM; Biasi D
    Clin Rheumatol; 2007 Oct; 26(10):1795-6. PubMed ID: 17225929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mycophenolate mofetil in extensive Alopecia areata: no effect in seven patients.
    Köse O; Safali M; Bulent Tastan H; Gur AR
    Dermatology; 2004; 209(1):69-70. PubMed ID: 15237274
    [No Abstract]   [Full Text] [Related]  

  • 55. Reducing the incidence and severity of acute graft-versus-host disease.
    Dosal J; Kirsner RS
    J Invest Dermatol; 2012 Jan; 132(1):6. PubMed ID: 22158604
    [No Abstract]   [Full Text] [Related]  

  • 56. [Treating chronic severe hepatitis B patients with mycophenolate mofetil].
    Yang YF; Tan DM; Xie YT; Lu MH; Liu ZB; Sha XP; Liu GZ; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):392-3. PubMed ID: 15918985
    [No Abstract]   [Full Text] [Related]  

  • 57. Isomorphic disposition of chronic graft-versus-host disease in striae distensae.
    Girault PY; Waton J; Barbaud A; Bordigoni P; Schmutz JL
    J Eur Acad Dermatol Venereol; 2009 May; 23(5):574-5. PubMed ID: 19415807
    [No Abstract]   [Full Text] [Related]  

  • 58. Mycophenolate mofetil for chronic inflammatory demyelinating polyradiculoneuropathy: An open-label study.
    Radziwill AJ; Schweikert K; Kuntzer T; Fuhr P; Steck AJ
    Eur Neurol; 2006; 56(1):37-8. PubMed ID: 16914929
    [No Abstract]   [Full Text] [Related]  

  • 59. Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil.
    Gladstone DE; Golightly MG; Zamkoff KW
    Rheumatol Int; 2005 Oct; 25(8):635-6. PubMed ID: 15703955
    [No Abstract]   [Full Text] [Related]  

  • 60. Necrotizing herpetic retinopathy in kidney-transplanted patients on mycophenolate mofetil.
    Morión Grande M; Martín-Gómez MA; Quereda Castañeda A; López Jiménez V; Cabezas Fernández T
    Nefrologia; 2016; 36(5):575-577. PubMed ID: 27577044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.